Abstracts
Showing 800 abstracts.
High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial
Study
P1041
Authors
A C Hesseling, S Kim, S Madhi, S Nachman, H S Schaaf, A Violari, T C Victor, G McSherry, C Mitchell, M F Cotton, IMPAACT P1041 TeamIsoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants
Study
P1041
Authors
Jennifer J Kiser, Rui Zhu, David Z D'Argenio, Mark F Cotton, Raziya Bobat, George D McSherry, Shabir A Madhi, Vincent J Carey, Heiner I Seifart, Cedric J Werely, Courtney V FletcherLoss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa
Study
P1041
Authors
CA Beneri, B Zeldow, S Nachman, M Van der Linde, E Pillay, S Dittmer, S Kim, P Jean-Philippe, J Coetzee, R Bobat, E Hawkins, A Violari, P1041 TeamPrevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093)
Conference
IAS 2023
Study
P1093, P1093
Authors
Robert Nixon, Robert A. Smith, Geoffrey S. Gottlieb, Theodore D. Ruel, Andrew A. Wiznia, Lisa M. Frenkel, IMPAACT P1093 Team, Ceejay L. Boyce, Marley D. Bishop, Sheila M. Styrchak, Kevin Knowles, Cindy Vavro, Rohan Hazra, Ellen TownleyINFANT AND ADULT VRC07-523LS POPULATION PHARMACOKINETIC MODELING TO PREDICT HIV PREVENTION IN BREASTFED INFANTS
Conference
American College of Clinical Pharmacology
Study
P1112
Authors
Coleen K. Cunningham, Elizabeth J. McFarland, Petronella Muresan, Charlotte Perlowski, Dwight Yin, Jack Moye, Lucio Gama, Martin Gaudinski, Edmund V. Capparelli, Dustin Huynh, Mina NikanjamGenotypic and Phenotypic Dolutegravir Resistance in Pregnant Women and Children Living with HIV-1
Conference
International Workshop on HIV Drug Resistance and Treatment Strategies
Study
IMPAACT 2010, P1093
Authors
TD Ruel, A Wiznia, S Lockman, L Chinula, PK Drain, GS Gottlieb, LM Frenkel, CL Boyce, RA Smith, R Nixon, MD Bishop, SM Styrchak, K Knowles, S BrummelPrevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093)
Conference
IAS 2023
Authors
Ceejay BoyceAdverse pregnancy outcomes and isoniazid exposure during pregnancy: a systematic review and individual participant data meta-analysis of WLHIV in randomized TB prevention trials
Conference
The Union World Conference on Lung Health
Study
P1078
Authors
Tichoana Vhembo, Adriana Weinberg, Gerhard Theron, Amita Gupta, Grace Montepiedra, Priya Singh, Lisa Aaron, Susan Swindells, Richard E. Chaisson, Allan Taylor, Renaud BecquetBreast Milk Transfer and Infant Exposures to DTG, TAF, and TFV: Results from IMPAACT 2010/VESTED
Conference
CROI 2024
Study
IMPAACT 2010
Authors
Tsungai Mhembere, Tariro Chawana, Deo Wabwire, Violet Korutaro, Shahin Lockman, Lameck Chinula, Jeremiah Momper, IMPAACT 2010/VESTED Protocol Team, Tk Nguyen, Jung-Woo Chae, Lauren Ziemba, Anne Coletti, Kevin Knowles, Benjamin Johnston, Patrick Jean-PhilippeLONG-ACTING CABOTEGRAVIR PLUS RILPIVIRINE IN ADOLESCENTS WITH HIV: WEEK 24 IMPAACT 2017 STUDY
Conference
CROI 2024
Study
IMPAACT 2017